4.6 Review

Translational and Clinical Applications of Dental Stem Cell-Derived Exosomes

期刊

FRONTIERS IN GENETICS
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2021.750990

关键词

dental stem cells; exosomes; regenerative medicine; tissue repair; clinical application

资金

  1. National Natural Science Foundation of China [81901006]

向作者/读者索取更多资源

Mesenchymal stem cells exert biological functions through secreting exosomes, which play important roles in regenerative medicine and possess various advantages. Exosomes derived from dental stem cells actively participate in multiple biological processes and demonstrate promising clinical application potential.
Mesenchymal stem cells (MSCs) are promising seed cells in tissue repair and regeneration due to their featured properties of self-renewal and multipotency. However, a growing body of evidence has demonstrated that MSCs exert biological functions mainly through secreting exosomes. Exosomes, which contain RNA, proteins, lipids, and metabolites, are new players in regulating many fundamental processes and play important roles in regenerative medicine. Exosomes not only mimic the effects of their parent cells but also possess many advantages such as high drug loading capacity, low immunogenicity, excellent biocompatibility, and low side effects. Currently, a total of 6 different dental stem cells (DSCs) including dental pulp stem cells (DPSCs), stem cells from exfoliated deciduous teeth (SHEDs), periodontal ligament stem cells (PDLSCs), dental follicle progenitor cells (DFPCs), stem cells from apical papilla (SCAPs) and gingival mesenchymal stem cells (GMSCs) have been isolated and identified. DSC-derived exosomes (DSC-Exos) are actively involved in intercellular communication, anti-inflammation, osteogenesis, angiogenesis, immunomodulation, nurturing neurons, and promoting tumor cell apoptosis. In this review, we will critically review the emerging role and clinical application potential of DSC-Exos.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma

Li Cui, Huan Chen, Xinyuan Zhao

DIAGNOSTICS (2020)

Article Endocrinology & Metabolism

Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis

Li Cui, Xinyuan Zhao, Zhenning Jin, Hailin Wang, Shun-Fa Yang, Shen Hu

Summary: Metabolic remodeling is a hallmark of cancer, and in this study, it was found that melatonin inhibits the folate cycle through downregulation of MTHFD1L, thereby halting HNSCC progression.

JOURNAL OF PINEAL RESEARCH (2021)

Review Microbiology

Metagenomic and Metatranscriptomic Insight Into Oral Biofilms in Periodontitis and Related Systemic Diseases

Yi Huang, Xinyuan Zhao, Li Cui, Shaohong Huang

Summary: The oral microbiome is closely related to oral and systemic health, with dental plaque biofilms being the primary factor of periodontitis. Analyzing the composition and functional characteristics of microbial communities is crucial for understanding the pathogenesis of periodontitis.

FRONTIERS IN MICROBIOLOGY (2021)

Article Oncology

A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma

Zizhao Mai, Huan Chen, Mingshu Huang, Xinyuan Zhao, Li Cui

Summary: This study identified differentially expressed metabolic enzymes (DEMEs) in head and neck squamous cell carcinoma (HNSCC) tissues and constructed a prognostic signature and nomogram model for predicting the clinical outcome of HNSCC. The results showed that the DEME-based signature can effectively predict the prognosis of HNSCC and the nomogram model can provide personalized therapeutic guidance. In vitro experiments also demonstrated that the knockdown of one of the DEMEs suppressed malignant activities of HNSCC cells.

FRONTIERS IN ONCOLOGY (2022)

Article Dentistry, Oral Surgery & Medicine

FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1

Xinyuan Zhao, Huan Chen, Yu Qiu, Li Cui

Summary: The expression of FAM64A is significantly elevated in HNSCC tissues and cell lines, and is strongly associated with an unfavorable prognosis. Depletion of FAM64A suppresses the malignant activities of HNSCC cells both in vitro and in vivo. Mechanistically, FAM64A enhances the transcriptional activity of FOXM1 and modulates its expression through an autoregulation loop. These findings reveal a previously unknown mechanism behind the activation of FOXM1 in HNSCC and suggest that FAM64A could be a promising molecular therapeutic target.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2022)

Article Chemistry, Multidisciplinary

CeO2 nanoparticles induce pulmonary fibrosis via activating S1P pathway as revealed by metabolomics

Li Cui, Xiang Wang, Xinyuan Zhao, Bingbing Sun, Tian Xia, Shen Hu

Summary: In this study, a mass spectrometry-based global metabolomic analysis was conducted to investigate the metabolomic changes in BEAS-2B cells exposed to CeO2 nanoparticles (NPs) with different aspect ratios. The study revealed subtle changes in metabolic activities that traditional functional assays might have missed and discovered a previously unknown molecular mechanism underlying CeO2 NP-induced lung fibrosis with different aspect ratios.

NANO TODAY (2022)

Article Cell & Tissue Engineering

Circular RNA BIRC6 depletion promotes osteogenic differentiation of periodontal ligament stem cells via the miR-543/PTEN/PI3K/AKT/mTOR signaling pathway in the inflammatory microenvironment

Xinyuan Zhao, Wenjuan Sun, Bing Guo, Li Cui

Summary: This study found that downregulation of circBIRC6 can enhance the osteogenic potential of PDLSCs under inflammatory conditions, and circBIRC6 regulates the osteogenic differentiation of PDLSCs through miR-543. Furthermore, the circBIRC6/miR-543 axis regulates the mineralization capacity of PDLSCs in the inflammatory microenvironment via the PTEN/PI3K/AKT/mTOR signaling pathway. These findings may provide new targets and treatment strategies for bone loss in periodontitis.

STEM CELL RESEARCH & THERAPY (2022)

Article Oncology

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop

Xinyuan Zhao, Dalong Shu, Wenjuan Sun, Shanshan Si, Wei Ran, Bing Guo, Li Cui

Summary: In this study, it was found that PLEK2 expression was significantly increased in HNSCC tissues, and PLEK2 overexpression was strongly associated with poor overall survival and therapeutic resistance. PLEK2 played an important role in maintaining the malignant behaviors of HNSCC cells, altering cellular metabolism, and enhancing c-Myc signaling in HNSCC.

CANCER COMMUNICATIONS (2022)

Review Chemistry, Multidisciplinary

Diverse Pathways of Engineered Nanoparticle-Induced NLRP3 Inflammasome Activation

Xin Liao, Yudong Liu, Jiarong Zheng, Xinyuan Zhao, Li Cui, Shen Hu, Tian Xia, Shanshan Si

Summary: With the rapid development of engineered nanomaterials (ENMs) in biomedical applications, evaluating their biocompatibility and cytotoxicity has become crucial. Recent studies have shown that inflammasome activation, particularly the NLRP3 inflammasome's interaction with ENMs, plays a significant role in inducing inflammatory responses. Understanding the pathways linking ENMs to NLRP3 inflammasome activation is essential for safer nanomaterial designs and mitigating ENM-induced adverse health effects.

NANOMATERIALS (2022)

Review Cell & Tissue Engineering

Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration

Ye Lu, Zizhao Mai, Li Cui, Xinyuan Zhao

Summary: Mesenchymal stem cell-based therapy is effective for bone regeneration, but clinical translation has limitations. The secretome of mesenchymal stem cells, especially exosomes, has a critical role in bone repair and regeneration. Exosomes, with their nanosized structures and cargo of proteins, lipids, RNAs, growth factors, and cytokines, are being investigated for their potential in bone regenerative medicine. Preconditioning of parental cells and exosome engineering can enhance their regenerative potential, and biomaterial-assisted exosomes have emerged as a promising strategy for bone regeneration. This review discusses the roles of exosomes in bone regeneration, the use of engineered exosomes and biomaterial-assisted exosomes, and the current challenges in translating exosomes to clinical applications.

STEM CELL RESEARCH & THERAPY (2023)

Article Biochemistry & Molecular Biology

KLF9 Promotes Osteogenic Differentiation of Dental Stem Cells by Negatively Regulating Notch1 Mediated Signaling Pathway

Xinyuan Zhao, Zizhao Mai, Ye Lu, Li Cui, Jinhua Yu

Summary: This study found that KLF9 is a crucial transcription factor that controls the osteogenic differentiation of human dental stem cells (DSCs) by negatively regulating the Notch1 signaling pathway.

FRONTIERS IN BIOSCIENCE-LANDMARK (2023)

Article Chemistry, Multidisciplinary

Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC

Xinyuan Zhao, Bing Guo, Wenjuan Sun, Jinhua Yu, Li Cui

Summary: Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) is driven by squalene epoxidase (SQLE), which operates through a cholesterol-dependent pathway. SQLE stabilizes c-Myc protein and prevents its degradation, leading to the activation of c-Myc transcriptional activity. Inhibition of SQLE disrupts the binding of Akt to lipid rafts, deactivates Akt, and destabilizes c-Myc. In a mouse model, SQLE is found to be critical for HNSCC initiation and progression. The combination of terbinafine and cisplatin shows promising synergistic effects in arresting tumor growth. These findings provide insights into SQLE-mediated cisplatin resistance and propose a potential therapeutic avenue for HNSCC patients.

ADVANCED SCIENCE (2023)

Article Oncology

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma

Yu Qiu, Li Cui, Yang Lin, Bingju Gao, Jun Li, Xinyuan Zhao, Xiaofeng Zhu, Shen Hu, Lisong Lin

FRONTIERS IN ONCOLOGY (2020)

暂无数据